Prognosis
The prognosis cannot be formulated in a generalized way. A prognosis for osteosarcoma is always dependent on many individual factors, such as time of diagnosis, initial tumor size, localization, metastasis, response to chemotherapy, extent of tumor removal. It can be said, however, that a five-year survival rate of about 60% can be achieved with the modified form of therapy (see above).
Aftercare
Since recurrences cannot be ruled out, follow-up care should be provided. The following aftercare recommendation can be given, in individual cases an aftercare plan can deviate from this:
- A clinical examination should be performed every 1st and 2nd quarter of the year. This clinical examination usually includes a local x-ray checkup and laboratory tests.
In addition, a CT of the rib cage and a full-body skeletal scintigraphy are also performed. An MRI is usually performed every six months for the first two years.
- 3rd to 5th yearThe clinical examination is now performed every six months. Likewise, during the first and second year after the disease, the clinical examination usually includes a local X-ray control and laboratory tests.
In addition, a CT of the rib cage and a full-body skeletal scintigraphy are also performed. A local MRT is now performed annually.
- From the 6th year on, the clinical examination is usually repeated once a year. It includes a local x-ray control as well as laboratory tests. In addition, a CT of the thorax (ribcage), a full-body skeletal scintigraphy and a local MRI are also performed.
